Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in C:\inetpub\wwwroot\technology_detail.php on line 331
 Technology Detail


The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Soluble CD81 Fusion Constructs


Stanford Reference:

98-122


Abstract


Soluble CD81 molecules were constructed for the purpose of identifying a postulated ligand to CD81. Recently CD81 has been claimed by others to be a candidate for a receptor for the human hepatitis C virus (HCV). The soluble CD81 could be used to block binding of viral proteins to cells.

Advantages


  • Such soluble constructs have not been made previously.

Publications


  • Proc. Natl. Acad. Sci 95: 2458 (March 1998)

Innovators & Portfolio



Date Released

 4/17/2015
 

Licensing Contact


Brenda Martino, Biological Materials Specialist
(650) 725-9119 (Direct)
Login to Request Information

[-] Map/Timeline

78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

more technologies »

Related Keywords


research tool   hepatitis C   research tool: cell line   
 

   

  

Also of Interest...
78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

Recently Viewed...
S98-122 Soluble CD81 Fusion Constructs